BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 16, 2005
View Archived Issues
Phase III ferumoxytol program recommended to continue by DMC
Read More
Cetilistat successfully completes U.S. study in obese subjects
Read More
ABT-894 begins phase I multidose trial for neuropathic pain
Read More
Triad Pharmaceuticals changes name to Arisaph Pharmaceuticals
Read More
European orphan drug designation for Bronchitol in cystic fibrosis
Read More
Phase I study for EVT-101
Read More
Phase III ACCLAIM trial of Celacade technology reaches target endpoint events
Read More
More sites for PROVIDENCE-1 study of rifalazil in intermittent claudication
Read More
Phase I study for NGX-424 for intractable pain
Read More
Promising antinociceptive effects of a novel P2X7 receptor antagonist from Abbott
Read More
CYC-116 begins IND-directed preclinical development
Read More
Fuji Pharma and JCR dissolve codevelopment agreement for JR-013
Read More
M-43068: A novel analgesic agent with reduced side effect profile
Read More
JDY-8112 protects dopaminergic neurons against inflammatory damage
Read More
AMG-0347: a novel, potent and selective TRPV1 antagonist
Read More
FDA approves new indication for Invanz
Read More
Novel histamine H3 receptor antagonists revealed by Lilly
Read More
Priority review granted for Japanese Baraclude submission
Read More
AP-23573 receives E.U. orphan drug designation for soft-tissue and bone sarcomas
Read More
Approvable letter for Thalomid sNDA for multiple myeloma
Read More
Procoralan receives European approval for chronic stable angina
Read More
New data support the use of sulodexide in the treatment of diabetic nephropathy
Read More
First data on the E1E2/MF59C.1 hepatitis C vaccine in humans
Read More
New data on the antiviral effects of Albuferon plus ribavirin in chronic hepatitis C
Read More
HepeX-B shows promise in the prevention of immune escape in HBV-infected patients
Read More
Interferon omega effective in phase II chronic hepatitis C study
Read More
Polyenylphosphatidylcholine improves peginterferon-ribavirin HCV treatment
Read More
Telbivudine superior to lamivudine in phase III hepatitis B trial
Read More
Novel agents for the treatment of neurological disorders disclosed in recent patents
Read More
Novel therapeutics for gastrointestinal disorders claimed in recent Altana patent
Read More
Novel agents for HIV infection imparted in recent patent literature
Read More